DRUG · COUNSELLING NOTES
Durvalumab
IMFINZI
Updated
New prescription
indication: _____. IV in clinic; report cough, SOB, diarrhea, rash; warned on allergies; serious/common AEs: immune colitis/pneumonitis, infusion reaction; non-pharm: activity pacing, hand hygiene.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV in clinic; report cough, SOB, diarrhea, rash; warned on allergies; serious/common AEs: immune colitis/pneumonitis, infusion reaction; non-pharm: activity pacing, hand hygiene.